← back to search

Jian Payandeh

Exelixis (United States) · US
Area of research
Molecular Biology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Ion channel regulation and function, Monoclonal and Polyclonal Antibodies Research, Nicotinic Acetylcholine Receptors Study, and Bacterial Genetics and Biotechnology.
h-index
39
citations
8,020
works
103
NIH funding
primary concept
Biology
email

Recent publications

The discovery and structural basis of two distinct state-dependent inhibitors of BamA.
2024cited by 14position: contributordoi
Structural basis of antibody inhibition and chemokine activation of the human CC chemokine receptor 8
Nature Communications 2023cited by 27position: middledoi
Structural basis of antibody inhibition and chemokine activation of the human CC chemokine receptor 8.
2023cited by 19position: contributordoi
Structure of the core human NADPH oxidase NOX2
Nature Communications 2022cited by 101position: middledoi
Structure of the core human NADPH oxidase NOX2.
2022cited by 77position: contributordoi
Structural architecture of the human NALCN channelosome.
2022cited by 30position: contributordoi
Structural basis for HCMV Pentamer receptor recognition and antibody neutralization.
2022cited by 30position: contributordoi
Structure-guided unlocking of NaX reveals a non-selective tetrodotoxin-sensitive cation channel
Nature Communications 2022cited by 26position: lastdoi
Structure-guided unlocking of Na<sub>X</sub> reveals a non-selective tetrodotoxin-sensitive cation channel.
2022cited by 23position: contributordoi
Corrigendum to “A novel method to produce synthetic murine CXCL10 for efficient screening of functional variants” [Bioorg. Chem. 116 (2021) 105376]
Bioorganic Chemistry 2022cited by 0position: middledoi
NINJ1 mediates plasma membrane rupture during lytic cell death
Nature 2021cited by 789position: middledoi
NINJ1 mediates plasma membrane rupture during lytic cell death.
2021cited by 624position: contributordoi
A TRPA1 inhibitor suppresses neurogenic inflammation and airway contraction for asthma treatment
Journal of Experimental Medicine 2021cited by 127position: contributordoi
Ligand binding at the protein–lipid interface: strategic considerations for drug design
Nature Reviews Drug Discovery 2021cited by 120position: firstdoi
Structural Pharmacology of Voltage-Gated Sodium Channels
Journal of Molecular Biology 2021cited by 77position: lastdoi
Structural Pharmacology of Voltage-Gated Sodium Channels
Journal of Molecular Biology 2021cited by 70position: contributordoi
Structures of HCMV Trimer reveal the basis for receptor recognition and cell entry
Cell 2021cited by 52position: middledoi
Structural architecture of the human NALCN channelosome
Nature 2021cited by 42position: lastdoi
Potent Killing of Pseudomonas aeruginosa by an Antibody-Antibiotic Conjugate
mBio 2021cited by 40position: contributordoi
A novel method to produce synthetic murine CXCL10 for efficient screening of functional variants
Bioorganic Chemistry 2021cited by 2position: middledoi
Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab.
2020cited by 151position: contributordoi
Structure of the essential inner membrane lipopolysaccharide–PbgA complex
Nature 2020cited by 97position: middledoi
A Non-covalent Ligand Reveals Biased Agonism of the TRPA1 Ion Channel
Neuron 2020cited by 93position: middledoi
Structure of the human sodium leak channel NALCN
Nature 2020cited by 74position: lastdoi
Structure of the essential inner membrane lipopolysaccharide-PbgA complex.
2020cited by 74position: contributordoi
Structure of the human sodium leak channel NALCN.
2020cited by 53position: contributordoi
NINJ1 mediates plasma membrane rupture during lytic cell death
2020cited by 7position: contributordoi
Structural basis of α-scorpion toxin action on Na <sub>v</sub> channels
Science 2019cited by 192position: lastdoi
Structural Basis of Nav1.7 Inhibition by a Gating-Modifier Spider Toxin
Cell 2019cited by 184position: lastdoi
A Flexible and Scalable High-Throughput Platform for Recombinant Membrane Protein Production
Methods in molecular biology 2019cited by 3position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 13 papers (2020–2024)Christopher P. Arthur · University of Colorado Boulder7 papers (2019–2022)Claudio Ciferri · University of California, Berkeley6 papers (2019–2022)Claudio Ciferri · SpringerNature6 papers (2020–2024)Cameron L. Noland · Merck & Co., Inc., Rahway, NJ, USA (United States)5 papers (2020–2022) · 5 papers (2017–2023) · 4 papers (2018–2023)Alexis Rohou · Imperial College London4 papers (2019–2021)Thomas Clairfeuille · University of Queensland4 papers (2016–2020)David H. Hackos · Neurological Surgery4 papers (2018–2020)Marc Kschonsak · European Bioinformatics Institute4 papers (2020–2022)Laëtitia Comps‐Agrar · Gene Therapy Laboratory4 papers (2018–2023)Christopher M. Koth · Gene Therapy Laboratory4 papers (2016–2019)Han Chow Chua · The University of Sydney3 papers (2020–2022)Ning Zheng · Beijing Institute of Technology3 papers (2012–2014)Matthew C. Johnson · Seattle University3 papers (2021–2023)James T. Koerber · Research & Diagnostic Antibodies (United States)3 papers (2018–2023)Tianbo Li · Jiangsu University3 papers (2019–2021)Stephan A. Pless · Institute of Cell Biology3 papers (2020–2022)James T. Koerber · Research & Diagnostic Antibodies (United States)3 papers (2020–2023)